Clinical Trials Browser

Phase 1 × Extensive Stage Small Cell Lung Cancer × camrelizumab × Clear all

NCT05001412 2021-08-12

Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC

Phase 1 Unknown

Extensive Stage Small Cell Lung Cancer